Target intelligence / Profile preview

TTC29 antisense RNA 1 (TTC29-AS1)

Target: TTC29-AS1
Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA

Overview

TTC29 Antisense RNA 1 (TTC29-AS1) is a long non-coding RNA (lncRNA) gene, transcribed from the DNA strand opposite to the TTC29 protein-coding gene. As an antisense lncRNA, TTC29-AS1 is part of a class of RNA molecules that do not code for protein but may regulate the expression of genes, often in a locus-specific manner by interacting with chromatin or modulating transcription, although no specific function or disease association has yet been characterized for TTC29-AS1.

Mechanism of action

None known

Biological functions

Gene expression regulation (potential, inferred from molecular type)RNA-mediated gene regulatory processes (potential, as for other antisense lncRNAs)

Disease associations

Other

Beyond the preview

Go deeper on TTC29 antisense RNA 1 (TTC29-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TTC29 antisense RNA 1 (TTC29-AS1).

Explore the full profile